Session: Moderated Oral ePoster Session 06 - Bladder Cancer - Clinical and Bladder Cancer - Basic Science
MP-04.09: Ongoing Trial: Bond-003 Cohort P- a Multi-National, Single-Arm Study of Intravesical Cretostimogene Grenadenorepvec for Treatment of High-Risk, Papillary only, BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
